AI-generated summary
The authors evaluated magnetic laser therapy in patients with stage I or II essential hypertension and examined whether gene polymorphisms of angiotensinogen, angiotensin-converting enzyme, type II bradykinin receptor and endothelial nitric oxide synthase influenced its blood pressure effect. They report that the hypotensive effect depended on these polymorphisms and was greatest in patients with certain angiotensinogen and angiotensin-converting enzyme genotypes, with an additive interaction between the two genes.
- Who or what was studied
- Patients with essential hypertension, stage I or II
- Limits stated in the abstract
- The abstract does not report sample size, control group or statistical details, so the strength of the genotype associations cannot be assessed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.